Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Var2 Pharmaceuticals
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Novartis
Celldex Therapeutics
Rutgers, The State University of New Jersey
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center